NeCEN contributes to improved Covid-19 vaccine

On July 10 a preprint was released on stabilizing the trimeric spike protein of Sars-CoV-2. This protein constitutes the main focus of most vaccine development efforts. The research for this article was a collaboration between Janssen Vaccines & Prevention BV and NeCEN.


The full text can be found on the BioRxiv website.